ホーム › 肝臓がん（肝細胞がん） › テキサス › Dallas
Dallas、TXにおける肝臓がん（肝細胞がん）の臨床試験
Dallasとその周辺地域（約30マイル以内）の拠点で、肝臓がん（肝細胞がん）に関する19件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
被験者募集中第1相
- Exelixis Clinical Site #89, Dallas
National Liver Cancer Screening Trial
被験者募集中第4相
- UT Southwestern Medical Center and Parkland Hospital, Dallas
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
被験者募集中第1/2相
- University of Texas Southwestern, Harold C. Simmons Comprehensive Cancer Center, Dallas
THIO and Cadonilimab in Resectable Hepatocellular Carcinoma
被験者募集中早期第1相
- University of Texas Southwestern Medical Center, Dallas
Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
被験者募集中第2相
- University of Texas Southwestern Medical Center, Dallas
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
被験者募集中第1/2相
- Texas Oncology, P.A., Dallas
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
被験者募集中第2相
- Baylor Scott & White Research Institute, Dallas
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
被験者募集中第1相
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- UT Southwestern Medical Center - Redbird, Dallas
- Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital, Dallas
- 他2件
CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
被験者募集中
- University of Texas Southwestern Medical Center, Dallas
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
被験者募集中第1相
- Clinical Trial Site, Dallas
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
被験者募集中
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
被験者募集中第1/2相
- Harold C. Simmons Comprehensive Cancer Center, Dallas
Evaluation of Resection Techniques for Pancreatic Tumors
被験者募集中観察研究
- Methodist Dallas Medical Center, Dallas
Ligufalimab and Cadonilimab in Advanced Liver Cancers
被験者募集中第2相
- University of Texas Southwestern Medical Center, Dallas
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
被験者募集中第4相
- UT Southwestern Medical Center, Dallas
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
被験者募集中第1/2相
- Research Site 120, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Dallas
EGCG for Hepatocellular Carcinoma Chemoprevention
被験者募集中第2相
- UT Southwestern, Dallas
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
被験者募集中第3相
- Site 881, Dallas
他の都市における肝臓がん（肝細胞がん）の試験
- Houston, TX31件の研究
- New York City, NY24件の研究
- Los Angeles, CA19件の研究
- Boston, MA18件の研究
- Cleveland, OH18件の研究
- Chicago, IL16件の研究
- Philadelphia, PA16件の研究
- Pittsburgh, PA15件の研究
- San Francisco, CA14件の研究
- Orange, CA14件の研究
- Jacksonville, FL14件の研究
- San Antonio, TX13件の研究
Dallasにおける他の研究
- 乳がん55件の研究
- 非小細胞肺癌52件の研究
- 転移性癌42件の研究
- 心不全42件の研究
- がん（全種類）37件の研究
- 前立腺がん36件の研究
- 大腸癌33件の研究
- 肥満症30件の研究
- 卵巣がん28件の研究
- 肺がん27件の研究
- 膀胱癌27件の研究
- 子宮内膜がん24件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。